A potential role for CD8+ T-cells as regulators of CNS vascular permeability

REFERENCES

• Dallasta LM, Pisarov LA, Esplen JE, et al. Blood—brain barrier tight junction disruption in human immunodeficiency virus-1 encepha-litis. Am Pathol 1999; 155: 1915–1927
   PubMed Web of Science ®Google Scholar
• Janssen HL, Bienfait HP, Jansen CL, et al. Fatal cerebral oedema associated with primary dengue infection. J Infect 1998; 36: 344–346
   PubMed Web of Science ®Google Scholar
• Williams KC, Hickey WF. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002; 25: 537–562
   PubMed Web of Science ®Google Scholar
• Vos CM, Geurts JJ, Montagne L, et al. Blood—brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis 2005; 20: 953–960
   PubMed Web of Science ®Google Scholar
• Plumb J, McQuaid S, Mirakhur M, et al. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002; 12: 154–169
   PubMed Web of Science ®Google Scholar
• Minagar A, Alexander JS. Blood—brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9: 540–549
   PubMed Web of Science ®Google Scholar
• Kirk J, Plumb J, Mirakhur M, et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood—brain barrier leakage and active demyelina-tion. J Pathol 2003; 201: 319–327
   PubMed Web of Science ®Google Scholar
• Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355: 1053–1059
   PubMed Web of Science ®Google Scholar
• Ehrlich P. Das Sauerstoftbediirfnis des Organismus. Eine farbana-lytische Studie, Berlin, Germany: Hirschwald, 1885
   Google Scholar
• Goldmann E. Vitalfarbung am zentralnervensystem. Anh Preuss Akad Wiss Phys Math 1913; 1: 1–60
   Google Scholar
• Hawkins BT, Davis TP. The blood—brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005; 57: 173–185
   PubMed Web of Science ®Google Scholar
• Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl .1 Med 2000; 343: 938-952
   Google Scholar
• Woodroofe MN, Bellamy AS, Feldmann M, et al. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 1986; 74: 135–152
   PubMed Web of Science ®Google Scholar
• Booss J, [sin i MM, Tourtellotte VVVV, et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983; 62: 219–232
   PubMed Web of Science ®Google Scholar
• Trapani JA, Davis J, Sutton VR, et al. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 2000; 12: 323–329
   PubMed Web of Science ®Google Scholar
• Shresta S, Pham CT, Thomas DA, et al. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998; 10: 581–587
   PubMed Web of Science ®Google Scholar
• Johnson AJ, Mendez-Fernandez Y, Moyer AM, et al. Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol 2005; 174: 6854–6862
   PubMed Web of Science ®Google Scholar
• Chang WL, Jones SP, Lefer DJ, et al. CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect Immun 2001; 69: 7341–7348
   PubMed Web of Science ®Google Scholar
• Abbott NJ. Astrocyte-endothelial interactions and blood—brain barrier permeability. J Anat 2002; 200: 629–638
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. The blood—brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1–13
   PubMed Web of Science ®Google Scholar
• Maxwell K, Berliner JA, Cancilla PA. Induction of gamma-glutamyl transpeptidase in cultured cerebral endothelial cells by a product released by astrocytes. Brain Res 1987; 410: 309–314
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Risau W, Wolburg H. Induction of blood—brain barrier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture. Ann NY Acad Sci 1991; 633: 578–580
   PubMed Web of Science ®Google Scholar
• Janzer RC, Raff MC. Astrocytes induce blood—brain barrier properties in endothelial cells. Nature 1987; 325: 253–257
   PubMed Web of Science ®Google Scholar
• Petty MA, Lo EH. Junctional complexes of the blood—brain barrier: Permeability changes in neuroinflammation. Prog Neurobiol 2002; 68: 311–323
   PubMed Web of Science ®Google Scholar
• Kubota K, Furuse M, Sasaki H, et al. Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr Biol 1999; 9: 1035–1038
   PubMed Web of Science ®Google Scholar
• Brooks TA, Hawkins BT, Huber JD, et al. Chronic inflammatory pain leads to increased blood—brain barrier permeability and tight junction protein alterations. Am] Physiol Heart Circ Physiol 2005; 289: H738—H743
   PubMed Web of Science ®Google Scholar
• Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood—brain barrier. Exp Neurol 2004; 190: 446–455
   PubMed Web of Science ®Google Scholar
• Oshima T, Laroux FS, Coe LL, et al. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res 2001; 61: 130–143
   PubMed Web of Science ®Google Scholar
• Burns AR, Bowden RA, MacDonell SD, et al. Analysis of tight junctions during neutrophil transendothelial migration. J Cell Sci 2000; 113: 45–57
   PubMed Web of Science ®Google Scholar
• Oshima T, Blaschuk 0, Gour B, et al. Tight junction peptide antagonists enhance neutrophil trans-endothelial chemotaxis. Life Sci 2003; 73:1729–1740
   PubMed Web of Science ®Google Scholar
• Wolburg H, Wolburg-Buchholz K, Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol (Berl) 2005; 109: 181–190
   PubMed Web of Science ®Google Scholar
• Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003; 9: 921–927
   PubMed Web of Science ®Google Scholar
• Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991; 88: 1473–1480
   PubMed Web of Science ®Google Scholar
• Kurane I, Innis BL, Hoke CH, Jr, et al. T cell activation in vivo by dengue virus infection. J Clin Lab Immunol 1995; 46: 35–40
   PubMedGoogle Scholar
• Stephens HA, Klaythong R, Sirikong M, et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002; 60: 309–318
   PubMed Web of Science ®Google Scholar
• Kilpatrick ED, Terajima M, Koster FT, et al. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 2004; 172: 3297–3304
   PubMed Web of Science ®Google Scholar
• Zivna I, Green S, Vaughn DW, et al. T cell responses to an HLA-B*07-restricted epitope on the dengue N53 protein correlate with disease severity. J Immunol 2002; 168: 5959–5965
   PubMed Web of Science ®Google Scholar
• Johnson AJ, Roehrig JT. New mouse model for dengue virus vaccine testing. J Virol 1999; 73: 783–786
   PubMed Web of Science ®Google Scholar
• Raut CG, Deolankar RP, Kolhapure RM, et al. Susceptibility of laboratory-bred rodents to the experimental infection with dengue virus type 2. Acta Virol 1996; 40: 143–146
   PubMed Web of Science ®Google Scholar
• Puglielli MT, Browning JL, Brewer AW, et al. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway. Nat Med 1999; 5: 1370–1374
   PubMed Web of Science ®Google Scholar